Sarilumab for the Treatment of Ankylosing Spondylitis: Results of a Phase II, Randomised, Double-Blind, Placebo-Controlled Study (ALIGN)
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2013-204963
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2014
Authors
Publisher
BMJ